I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Image_1_Treatment Options of First-Line Tyrosine Kinase Inh..:
Sheng-Kai Liang
;
Li-Ta Keng
;
Chia-Hao Chang
...
doi:10.3389/fonc.2020.590356.s002. , 2021
Link:
https://doi.org/10.3389/fonc.2020.590356.s002
RT Journal T1
Image_1_Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort.tiff
UL https://suche.suub.uni-bremen.de/peid=base-ftfrontimediafig:oai:figshare.com:article_13547630&Exemplar=1&LAN=DE A1 Sheng-Kai Liang A1 Li-Ta Keng A1 Chia-Hao Chang A1 Yueh-Feng Wen A1 Meng-Rui Lee A1 Ching-Yao Yang A1 Jann-Yuan Wang A1 Jen-Chung Ko A1 Jin-Yuan Shih A1 Chong-Jen Yu YR 2021 K1 Cancer K1 Cancer Cell Biology K1 Cancer Diagnosis K1 Cancer Genetics K1 Cancer Therapy (excl. Chemotherapy and Radiation Therapy) K1 Chemotherapy K1 Haematological Tumours K1 Molecular Targets K1 Radiation Therapy K1 Solid Tumours K1 Oncology and Carcinogenesis not elsewhere classified K1 lung adenocarcinoma K1 gefitinib K1 erlotinib K1 afatinib K1 epidermal growth factor receptor mutation K1 subsequent therapy JF doi:10.3389/fonc.2020.590356.s002 LK http://dx.doi.org/https://doi.org/10.3389/fonc.2020.590356.s002 DO https://doi.org/10.3389/fonc.2020.590356.s002 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)